flow trial semaglutide kidney outcomes 2024 results in patients with overweight or obesity and chronic disease without diabetes: a randomized double-blind placebo-controlled clinical FLOW Trial Shows Benefit of

A dose-escalation study Appetite

Stomach Pain and Bloating: As digestion slows down, food remains in the stomach longer, which can lead to a feeling of fullness, bloating, and mild abdominal cramping

Our quick, in-office B12 treatments help restore optimal levels, making them ideal for individuals experiencing fatigue, brain fog, or low stamina

These effects usually go away within a few days

Nutritional and lifestyle supportive care recommendations for management of obesity with GLP-1 based therapies: An expert consensus statement using a modified Delphi approach

Zepbound , on the other hand, features tirzepatide , which uniquely activates both GLP-1 and GIP receptors